05/09/2024
5:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
5:59 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:02 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:03 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:04 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/09/2024
6:06 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:07 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:08 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:56 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:58 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:31 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:32 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:33 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:34 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:35 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:36 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:37 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:39 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:25 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:48 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:17 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
6:18 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:19 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:20 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:22 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:24 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:25 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:59 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:00 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
7:01 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
7:44 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:50 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad) In January 2021, Donald Trump silently rolled out a special gift to the American public…
One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. |
05/01/2024
6:50 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:51 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:53 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:54 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:55 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:04 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:05 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:07 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:09 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:10 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:11 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:12 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:58 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:59 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:00 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:34 PM | Amgen (Issuer)
Santos Esteban (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:24 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:25 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:26 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:27 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:29 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:30 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:32 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:23 PM | Amgen (Issuer)
Bradway Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Amgen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:50 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
10:35 AM | Amgen (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/19/2023
7:38 PM | Amgen (Issuer)
Bradner James E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2023
8:16 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:40 PM | Amgen (Subject)
Grygiel Nancy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
6:41 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
7:44 PM | Amgen (Issuer)
REESE DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:30 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
1:11 PM | Amgen (Subject)
Graham Jonathan P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:06 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:09 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:10 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:12 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:15 PM | Amgen (Issuer)
Grygiel Nancy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:16 PM | Amgen (Issuer)
Khosla Rachna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:20 PM | Amgen (Issuer)
Miller Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:43 PM | Amgen (Issuer)
Graham Jonathan P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
6:44 PM | Amgen (Issuer)
Griffith Peter H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
6:15 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:35 PM | Amgen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/05/2023
6:43 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
6:30 AM | Amgen (Filed by)
Neumora Therapeutics, Inc. (Subject)
| Form SC 13D | |
09/19/2023
6:52 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
5:58 PM | Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
09/12/2023
6:30 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
8:12 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
8:25 AM | Amgen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:36 PM | Amgen (Issuer)
Busch Matthew C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
5:13 PM | Amgen (Issuer)
Gordon Murdo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:55 PM | Amgen (Issuer)
Drake Michael V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:56 PM | Amgen (Issuer)
ISHRAK OMAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:57 PM | Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
2:18 PM | Amgen (Subject)
Gordon Murdo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
